Related Experiment Video
Updated: Jul 19, 2026
06:55
Assessment of Maternal Vascular Remodeling During Pregnancy in the Mouse Uterus
Published on: December 5, 2015
[Marfan's syndrome and pregnancy].
1Service de Gynécologie Obstétrique, Pavillon K, Hôpital Edouard-Herriot, place d'Arsonval, 69437 Lyon Cedex 03.
Journal De Gynecologie, Obstetrique Et Biologie De La Reproduction
|September 28, 2006
Summary
Marfan syndrome patients can safely experience pregnancy with careful monitoring and management. Key guidelines include medication use, regular echocardiography, and delivery method based on aortic root diameter.
Area of Science:
- Genetics
- Cardiology
- Obstetrics
Background:
- Marfan syndrome is an autosomal dominant disorder affecting connective tissue, primarily impacting ocular, skeletal, and cardiovascular systems.
- Aortic dilatation and dissection are major complications, with pregnancy posing an increased risk.
Observation:
- Guidelines for obstetric care in pregnant Marfan syndrome patients were developed based on clinical experience and literature review.
- Women with an aortic root diameter greater than 40 mm are advised to avoid pregnancy.
- B-adrenergic receptor blockers are recommended for all pregnant individuals with Marfan syndrome.
Findings:
- Prenatal diagnosis should be offered due to a 50% inheritance risk.
- Regular echocardiography (every 3 months during pregnancy and 2 months postpartum) is crucial.
- Delivery route is determined by aortic root diameter: vaginal delivery for <40 mm, Cesarean section for >40 mm.
- No significant increase in obstetrical complications was observed with appropriate supervision.
Implications:
- Establishing clear obstetric care guidelines improves outcomes for pregnant women with Marfan syndrome.
- Early intervention with B-adrenergic blockers and vigilant monitoring can mitigate cardiovascular risks.
- Informed reproductive choices can be made through prenatal diagnosis and risk assessment.
Related Concept Videos
01:19Mitral Valve Prolapse III: Nursing Management
The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
01:07Teratogenicity
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
01:30Aneurysm I: Introduction
An aortic aneurysm is a localized outpouching or dilation at a weak point in the artery wall. It may involve different parts of the aorta, such as the abdominal aorta, aortic arch, or thoracic aorta.Etiological factorsSeveral disorders are associated with aortic aneurysms.Congenital causes, such as primary connective tissue disorders like Marfan syndrome, impact the integrity and strength of connective tissues, notably affecting the aorta. Marfan syndrome is a genetic disorder that specifically...
01:27Mitral Valve Prolapse I: Introduction
IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...